William Blair research analyst Matt Phipps joined CNBC’s “Worldwide Exchange” to discuss the implications for pharmaceutical companies that have their drugs listed on Medicare’s price negotiation roster.
Equity Research
Matt Phipps Guests on CNBC
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
-
-
Vertiv Holdings Co.: Initiation of Research Coverage
William Blair initiated research coverage of Vertiv Holdings Co. (VRT $130.87), a global leader in the manufacturing, design, and servicing of critical digital infrastructure for data centers, communication networks, and commercial and industrial end-markets.